- Market Capitalization, $K 72,030,624
- Shares Outstanding, K 15,727,211
- Annual Sales, $ 13,743 M
- Annual Income, $ 3,016 M
- 60-Month Beta 0.71
- Price/Sales 5.43
- Price/Cash Flow 17.24
- Price/Book 4.49
|Period||Period Low||Period High||Performance|
| || |
-0.03 (-0.65%)since 09/23/19
| || |
-0.17 (-3.55%)since 07/23/19
| || |
+0.16 (+3.59%)since 10/23/18
Outlook for Alcohol Industry Dim on Soft Beer Sales & Tariffs
Ambev (ABEV) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Ambev has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
AB InBev (BUD) is a favored stock due to strong sales trends, strength in global brands and robust outlook. However, soft earnings trend due to currency headwinds and cost inflation cannot be ignored.
Boston Beer (SAM) enters into a merger agreement with Dogfish Head Brewery in a cash and stock deal worth about $300 million.
The Zacks Analyst Blog Highlights: Unilever, General Mills, Sysco, Kimberly-Clark and Ambev
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Scotts Miracle-Gro, Ambev, International Game Technology and Ubisoft Entertainment
With the trade war likely to intensify, consumer staples stocks are a prudent choice for investors.
Sin stocks provide a stable stream of consumers, irrespective of market conditions, which leads to higher margins and solid profits.
AB InBev (BUD) reports strong organic sales growth and top-line beat in first-quarter 2019 on strong volume growth, global premiumization and ongoing revenue-management initiatives.
|Latin America 40 Ishares ETF|
|Principal Active Global Dividend Income ETF|
|FTSE All-World Ex-US ETF Vanguard|
|Emrg Mkts ETF MSCI Vanguard|
|SPDR Emerging Markets Portfolio ETF|